Resultado de búsqueda
Jeff Leek and Lucy McGowan. When a new drug gets tested, the results of the trials should be published for the rest of the medical world -- except much of the time, negative or inconclusive findings go unreported, leaving doctors and researchers in the dark. In this impassioned talk, Ben Goldacre explains why these unreported instances of ...
Ben Michael Goldacre 1, né en 1974, est un écrivain scientifique britannique, docteur en médecine et psychiatre 2. Il est l'auteur de la rubrique Bad Science (« mauvaise science ») dans le journal The Guardian 3 et du livre du même nom édité par Fourth Estate en septembre 2008 4 . Goldacre est le fils des Australiens Michael Goldacre ...
26 de ene. de 2008 · Ben Goldacre. Fri 25 Jan 2008 20.19 EST. Share. I f there's one thing I love, it's academics who take on the work of investigative journalism, because they are dogged.
27 de sept. de 2012 · When a new drug gets tested, the results of the trials should be published for the rest of the medical world -- except much of the time, negative or inconclu...
17 de oct. de 2012 · This example doesn't make it into Ben Goldacre's Bad Pharma, his calmly outraged account of how the $600bn drug industry, doctors, academics, regulators and medical journals have let patients down.
Ben Goldacre is a doctor, writer, broadcaster and academic who specialises in unpicking dodgy scientific claims from drug companies, newspapers, government reports, PR people and quacks. Bad Science reached Number One in the non-fiction charts, has sold over 400,000 copies in the UK alone, and has been translated into 25 languages.
AllTrials is an international initiative of Ben Goldacre , BMJ , Centre for Evidence-based Medicine , Cochrane Collaboration , James Lind Initiative , PLOS and Sense about Science and is being led in the US by Sense About Science USA , Dartmouth’s Geisel School of Medicine and the Dartmouth Institute for Health Policy & Clinical Practice ...
